Found: 3
Select item for more details and to access through your institution.
First-in-human study of pbi-05204, an oleander-derived inhibitor of akt, fgf-2, nf-κΒ and p70s6k, in patients with advanced solid tumors.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
First-in-human study of pbi-05204, an oleander-derived inhibitor of akt, fgf-2, nf-κΒ and p70s6k, in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 6, p. 1204, doi. 10.1007/s10637-014-0127-0
- By:
- Publication type:
- Article
A phase 1 study of intermittently administered pazopanib in combination with continuous daily dosing of lapatinib in patients with solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 3, p. 597, doi. 10.1007/s00280-015-2824-6
- By:
- Publication type:
- Article